The Long and Short

Johnson Controls upgrade potential

| March 3, 2023

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

Johnson Control International’s fiscal first quarter results and fiscal 2023 guidance highlight that margins and free cash flow are moving in the right direction to be considered for an upgrade by Moody’s. The agency put JCI’s Baa2 rating on positive outlook in November last year, noting that ratings could be considered for an upgrade should EBITA margins improve, and free cash flow generation returns to historical levels well above $1.0 billion annually.  Free cash flow has resumed normalized seasonal patterns and working capital improvements set the stage for free cash flow to approach $2 billion this year, in line with historical free cash flow generation.  Additionally, management maintains a conservative approach to leverage with net leverage comfortably within management’s target range.

While JCI trades through peers such as Parker-Hannafin Corp (PH – Baa1(n)/BBB+(n)/BBB+(n)) and Trane Technologies PLC (TT – Baa2/BBB), JCI’s 2% 2031 bonds trade at a dollar discount to the company’s on the run 10-year bond (4.9% 2032) and provides for an approximate 10 bp to 12 bp pickup to the company’s 1.75% 2030 issue.  Specifically, the median average of spread differential between JCI’s 2031 and 2032 issues has been approximately 14 bp though the 2032 bonds.  Currently that spread differential is only 7 bp through.   JCI 2031 bonds have traded as tight as 29 bp through the 2032 bonds, as recent as January of this year.

Exhibit 1. Historical Spread Curve (JCI 2% 9/16/31 vs. JCI 4.9% 12/1/32)

Source: Bloomberg Trace, SanCap

EBITA margin witnessed solid growth

JCI witnessed strong adjusted EBITA growth of 15% in fiscal first quarter and posted an adjusted EBITA margin of 13.7%, a 140 bp improvement from the year-ago period.  Management noted that the improvement was driven by better pricing as well as improved productivity measures, which offset the negative impact from product mix.  On a LTM basis, JCI’s adjusted EBITA margin was 14.5%, up 30 bp sequentially and 10 bp year-over-year.  Given the strong quarterly growth, JCI is now guiding to full year EBITA margin growth in the 90 bp to 140 bp range, up from previous guidance of 80 bp to 140 bp.  That said, EBITA margins are expected to end the year in the 15.1% to 15.6% range.  Additionally, management provided second quarter guidance of adjusted EBITA margin growth in the 100 bp to 110 bp range.  Management remains confident in their guidance as they execute on their higher booked margin backlog as they move through the fiscal year.

Backlog remains at record levels

Management’s confidence in its guidance rests in the company’s backlog which was a record $11.3 billion at the end of the quarter, up 11% year-over-year.  JCI’s service backlog was a record $2.3 billion, and management believes the service component is a key competitive differentiator to peers. JCI noted that while supply chain realization and China polices related to their Covid lockdowns negatively impacted in-field order flow during the quarter, order momentum improved as they headed into fiscal second quarter.

Exhibit 2. JCI backlog 1Q21-1Q23

Source: JCI Earnings Presentation; SanCap

Service backlog witnessed 13% growth in the quarter as JCI saw strong growth across all regions.  JCI saw service orders and revenue growth of 10% in the quarter and remains confident in their ability to capture $2bn in additional service revenue by 2024.  Install backlog saw 10% growth in the quarter, which was primarily driven by North American order activity.  The North American business witnessed total order growth of 6%, with new construction orders (primarily in HVAC) growing over 50%. Energy efficiency and air quality post pandemic are expected to remain a tailwind, which bodes well for JCI as commercial HVAC accounts for just over 40% of JCI’s revenue base.

Free cash flow to improve as supply chain disruptions ease

Free cash flow returned to its normal seasonal pattern with a cash outflow in fiscal first quarter.  Additionally, management noted that free cash flow was negatively impacted by a softer residential market coupled with continued supply chain disruptions.  Full year free cash flow conversion is being guided to the 80%-90% range.  While below its historical conversion rate of 100% or more, it is a solid improvement from the 67% conversion rate posted in fiscal 2022.  The improvement is expected to be driven by better working capital management and the reduction in of inventory levels as the supply chain starts to normalize.   With cash flow moving back to more seasonal patterns, JCI will return to positive free cash flow generation in fiscal second quarter, with the expectation for a breakeven level for the first half of fiscal 2023.  Consensus estimates are calling for fiscal 2023 free cash flow to hover around $2.0 billion, in line with free cash flow generation in fiscal 2021.

Leverage within management’s target range

JCI ended the quarter with net leverage of 2.2x, within management’s target range of 2.0x-2.5x.  Total leverage stood at 2.6x which is roughly in line with Moody’s target of the mid-2.0x area.  JCI has long managed leverage conservatively and was below its target leverage range in fiscal fourth quarter of 2022 and fiscal first quarter of 2022.  Leverage is likely to improve as we move through the year and EBITA margins expand. Additionally, JCI benefits from strong liquidity, having ended the quarter with roughly $1.5 billion of cash on hand and $3.0 billion in untapped revolvers.  We anticipate that JCI is looking to extend the maturity of its current revolvers as $500 million is expected to mature on 11/30/23 and $2.5 billion to mature on 12/5/24.  JCI has only one debt maturity this fiscal year, with EUR888 million maturing on 9/15/23.

Meredith Contente
meredith.contente@santander.us
1 (646) 776-7753

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

Important disclaimers for clients in the EU and UK

This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).

The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.

This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.

This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.

This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.

The Library

Search Articles